FEMA550615

NAPSA Monoclonal Antibody (A9C1), Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 FEMA550615-Each-of-1 In Stock ₹ 41,741.00

FEMA550615 - Each of 1

₹ 41,741.00

In Stock

Quantity

1

Base Price: ₹ 41,741.00

GST (18%): ₹ 7,513.38

Total Price: ₹ 49,254.38

Antigen

NAPSA

Classification

Monoclonal

Concentration

2 mg/mL

Formulation

PBS with 0.1% BSA, 40% glycerol and 0.05% sodium azide; pH 7.4

Gene Accession No.

O96009

Gene Symbols

NAPSA

Immunogen

Recombinant protein within human NAPSIN A aa 51-200/420.

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human

Form

Liquid

Applications

Immunocytochemistry, Immunohistochemistry (Paraffin)

Clone

A9C1

Conjugate

Unconjugated

Gene

NAPSA

Gene Alias

asp 4, ASP4, Aspartyl protease 4, KAP, Kdap, KDAP-1, kidney-derived aspartic protease-like protein, Nap, NAP1, NAPA, Napsa, napsin A aspartic peptidase, napsin-1, Napsin-A, pronapsin, pronapsin A, SNAPA, TA01/TA02

Host Species

Mouse

Purification Method

Protein A

Regulatory Status

RUO

Gene ID (Entrez)

9476

Content And Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Isotype

IgG1

Related Products

Img

Thermo Scientific

FEMA550614

--

Img

Thermo Scientific

FEMA550619

--

Img

Thermo Scientific

FEMA550560

--

Img

Thermo Scientific

FEMA550650

--

Img

Thermo Scientific

FEMA550679

--

Img

Thermo Scientific

FEMA550701

--

Img

Thermo Scientific

FEMA550677

--

Img

Thermo Scientific

FEMA550757

--

Description

  • Positive control: Human kidney tissue, human lung carcinoma tissue, A549
  • Predicted band size: 45 kDa Subcellular Location: Secreted
  • Napsin 1 is an aspartic protease that is generally expressed in the lung, but also present in kidney and in metastatic carcinomas throughout the body
  • Napsin 1 processes surfactant protein B in healthy pulmonary and renal tissues, but is abnormally regulated when carcinogenesis occurs
  • Thus, many researchers have found napsin evaluation to be useful in identifying several cancers, and differentiating primary tumors from metastases
  • When combined with thyroid transcription factor analysis, napsin can be used as a specific biomarker for differentiation of carcinoma types
  • Napsin has also been associated with pulmonary alveolar proteinosis as well as in protein catabolism in renal tubules.